Total Payments
$18,910
2024 Payments
$4,914
Companies
7
Transactions
31
Medicare Patients
6,219
Medicare Billing
$212,290
Payment Breakdown by Category
Consulting$10,013 (52.9%)
Other$4,300 (22.7%)
Travel$3,647 (19.3%)
Food & Beverage$950.26 (5.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,013 | 5 | 52.9% |
| Honoraria | $4,300 | 1 | 22.7% |
| Travel and Lodging | $3,647 | 6 | 19.3% |
| Food and Beverage | $950.26 | 19 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Elucent Medical | $18,648 | 15 | $0 (2024) |
| Puma Biotechnology, Inc. | $94.92 | 6 | $0 (2019) |
| EISAI INC. | $49.79 | 3 | $0 (2019) |
| LEICA MICROSYSTEMS INC. | $37.99 | 2 | $0 (2018) |
| Celgene Corporation | $33.55 | 2 | $0 (2019) |
| Lilly USA, LLC | $33.06 | 2 | $0 (2019) |
| Amgen Inc. | $12.50 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,914 | 3 | Elucent Medical ($4,914) |
| 2023 | $13,089 | 9 | Elucent Medical ($13,089) |
| 2022 | $645.22 | 3 | Elucent Medical ($645.22) |
| 2019 | $223.82 | 14 | Puma Biotechnology, Inc. ($94.92) |
| 2018 | $37.99 | 2 | LEICA MICROSYSTEMS INC. ($37.99) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2024 | Elucent Medical | — | Honoraria | Cash or cash equivalent | $4,300.00 | General |
| 05/18/2024 | Elucent Medical | — | Travel and Lodging | Cash or cash equivalent | $346.00 | General |
| 05/18/2024 | Elucent Medical | — | Food and Beverage | Cash or cash equivalent | $267.67 | General |
| 10/09/2023 | Elucent Medical | — | Consulting Fee | In-kind items and services | $900.00 | General |
| 08/25/2023 | Elucent Medical | — | Consulting Fee | In-kind items and services | $1,800.00 | General |
| 07/10/2023 | Elucent Medical | — | Travel and Lodging | Cash or cash equivalent | $457.80 | General |
| 07/03/2023 | Elucent Medical | — | Consulting Fee | In-kind items and services | $3,600.00 | General |
| 06/24/2023 | Elucent Medical | — | Food and Beverage | Cash or cash equivalent | $275.56 | General |
| 06/06/2023 | Elucent Medical | — | Travel and Lodging | Cash or cash equivalent | $1,729.81 | General |
| 04/30/2023 | Elucent Medical | — | Consulting Fee | In-kind items and services | $2,612.50 | General |
| 01/30/2023 | Elucent Medical | — | Consulting Fee | In-kind items and services | $1,100.00 | General |
| 01/19/2023 | Elucent Medical | — | Travel and Lodging | Cash or cash equivalent | $613.80 | General |
| 09/16/2022 | Elucent Medical | — | Food and Beverage | Cash or cash equivalent | $145.22 | General |
| 09/09/2022 | Elucent Medical | — | Travel and Lodging | Cash or cash equivalent | $250.00 | General |
| 09/08/2022 | Elucent Medical | — | Travel and Lodging | Cash or cash equivalent | $250.00 | General |
| 12/18/2019 | Amgen Inc. | KANJINTI (Biological), Prolia, XGEVA | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Oncology | ||||||
| 12/10/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Oncology | ||||||
| 11/20/2019 | EISAI INC. | Halaven (Drug) | Food and Beverage | Cash or cash equivalent | $16.71 | General |
| Category: Oncology | ||||||
| 11/12/2019 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Oncology | ||||||
| 10/22/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Oncology | ||||||
| 10/09/2019 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Oncology | ||||||
| 09/18/2019 | EISAI INC. | Halaven (Drug) | Food and Beverage | Cash or cash equivalent | $17.15 | General |
| Category: Oncology | ||||||
| 09/03/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Oncology | ||||||
| 08/27/2019 | Celgene Corporation | Inrebic (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Myelofibrosis | ||||||
| 08/20/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 3,446 | 3,452 | $402,507 | $116,109 |
| 2022 | 13 | 1,548 | 1,567 | $206,280 | $52,082 |
| 2021 | 8 | 618 | 695 | $71,810 | $22,232 |
| 2020 | 5 | 607 | 615 | $65,320 | $21,868 |
Total Patients
6,219
Total Services
6,329
Medicare Billing
$212,290
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 950 | 950 | $114,000 | $36,005 | 31.6% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 946 | 946 | $94,600 | $28,567 | 30.2% |
| 77067 | Screening mammography | Facility | 2023 | 410 | 410 | $49,200 | $15,468 | 31.4% |
| 77063 | Screening 3d breast mammography | Facility | 2023 | 405 | 405 | $41,340 | $12,154 | 29.4% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Office | 2023 | 143 | 144 | $14,400 | $3,337 | 23.2% |
| 77066 | Diagnostic mammography of both breasts | Office | 2023 | 78 | 78 | $10,920 | $2,766 | 25.3% |
| 77065 | Diagnostic mammography of 1 breast | Office | 2023 | 76 | 77 | $9,240 | $2,448 | 26.5% |
| 76642 | Limited ultrasound scan of 1 breast | Office | 2023 | 86 | 86 | $9,460 | $2,304 | 24.4% |
| 77049 | Mri scan of both breasts | Facility | 2023 | 25 | 26 | $9,620 | $2,288 | 23.8% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2023 | 95 | 95 | $9,500 | $1,989 | 20.9% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2023 | 65 | 68 | $8,520 | $1,886 | 22.1% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2023 | 55 | 55 | $7,970 | $1,868 | 23.4% |
| 77049 | Mri scan of both breasts | Office | 2023 | 19 | 19 | $7,030 | $1,731 | 24.6% |
| 19083 | Biopsy of breast and placement of locating device using ultrasound, first growth | Facility | 2023 | 14 | 14 | $9,277 | $1,730 | 18.6% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2023 | 61 | 61 | $6,710 | $1,391 | 20.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2023 | 18 | 18 | $720.00 | $177.30 | 24.6% |
| 77067 | Screening mammography | Facility | 2022 | 469 | 469 | $56,280 | $17,923 | 31.8% |
| 77063 | Screening 3d breast mammography | Facility | 2022 | 313 | 313 | $37,560 | $9,768 | 26.0% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2022 | 120 | 122 | $20,740 | $4,269 | 20.6% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2022 | 132 | 139 | $19,460 | $4,068 | 20.9% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2022 | 137 | 143 | $16,500 | $3,695 | 22.4% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2022 | 146 | 148 | $14,800 | $3,298 | 22.3% |
| 19083 | Biopsy of breast and placement of locating device using ultrasound, first growth | Facility | 2022 | 25 | 25 | $14,500 | $2,954 | 20.4% |
| 77049 | Mri scan of both breasts | Facility | 2022 | 30 | 31 | $11,470 | $2,561 | 22.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2022 | 122 | 122 | $4,880 | $1,242 | 25.4% |
About Dr. Lisa Collazzo, MD
Dr. Lisa Collazzo, MD is a Diagnostic Radiology healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821083270.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lisa Collazzo, MD has received a total of $18,910 in payments from pharmaceutical and medical device companies, with $4,914 received in 2024. These payments were reported across 31 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($10,013).
As a Medicare-enrolled provider, Collazzo has provided services to 6,219 Medicare beneficiaries, totaling 6,329 services with total Medicare billing of $212,290. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Location Miami, FL
- Active Since 09/13/2005
- Last Updated 10/09/2024
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1821083270
Products in Payments
- Nerlynx (Drug) $94.92
- Halaven (Drug) $49.79
- NA (Device) $37.99
- VERZENIO (Drug) $33.06
- Abraxane (Drug) $18.79
- Inrebic (Drug) $14.76
- KANJINTI (Biological) $12.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Miami
Mr. James Benenati, Md, MD
Diagnostic Radiology — Payments: $6.5M
Diagnostic Radiology $6.5M
Mr. George Oliveira, M.d, M.D
Diagnostic Radiology — Payments: $1.4M
Diagnostic Radiology $1.4M
Guilherme Dabus, Md, MD
Diagnostic Radiology — Payments: $509,504
Diagnostic Radiology $509,504
Mr. Barry Katzen, Md, MD
Diagnostic Radiology — Payments: $445,306
Diagnostic Radiology $445,306
Dr. Italo Linfante, M.d, M.D
Diagnostic Radiology — Payments: $284,276
Diagnostic Radiology $284,276
Riccardo Lencioni, Md, MD
Diagnostic Radiology — Payments: $225,564
Diagnostic Radiology $225,564